Rare Disease Day

archive news 6


An Open Label Phase 2 Study of DEX-M74 in Subjects With GNE Myopathy

The National Institutes of Health in Bethedsa, Maryland. U.S.A. has started recruiting patients with gne-myopathy for a clinical trial using ManNac. They plan to treat 12 patients in the clinical trial.

Here is the link with very detailed information. If you have any questions, please feel free to send us an emailhttps://clinicaltrials.gov/ct2/show/NCT02346461?term=hibm&rank=10